Cannabliss is a mid-size Israeli Cannabis products manufacturer. As part of the new GMP regulations published in Israel, the company was willing to upgrade its GMP compliance. As part of the project, Cannabis GXP wrote SOPs and policies based on concurrent GMP regulations.

Recently the customer announced us that as part of a new partnership with investor, Cannabis GXP will have a turn key project for a new cannabis GMP facility, from the conceptual design phase until a final medical grade Cannabis product that will meet release specifications and final inspection of the facility by the IMOH.